comparemela.com

Vivoryon Therapeutics N.V. Reports Q1 2024 Financial Results And New Data Reinforcing Strategic Focus In Kidney Disease

Related Keywords

Netherlands ,Germany ,Amsterdam ,Noord Holland ,Kugan Sathiyanandarajah ,Frank Weber ,Manuela Bader ,Morten Asser Karsdal ,Valeria Fisher ,Danne Doering ,Trophic Communications ,Corporate Development Updates ,New Data Reinforcing Strategic Focus ,Kidney Disease ,Euronext Amsterdam ,Post Period Updates ,Non Executive Directors ,Chief Financial Officer ,Chief Strategy ,Investor Relations ,General Meeting ,First Quarter ,

comparemela.com © 2020. All Rights Reserved.